Q4 2021 13F Holders as of 12/31/2021
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
50.5M
-
Number of holders
-
80
-
Total 13F shares, excl. options
-
24.8M
-
Shares change
-
+1.36M
-
Total reported value, excl. options
-
$395M
-
Value change
-
+$18.7M
-
Put/Call ratio
-
0.83
-
Number of buys
-
42
-
Number of sells
-
-27
-
Price
-
$15.95
Significant Holders of Mirum Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (MIRM) as of Q4 2021
94 filings reported holding MIRM - Mirum Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share as of Q4 2021.
Mirum Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (MIRM) has 80 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 24.8M shares
of 50.5M outstanding shares and own 49.08% of the company stock.
Largest 10 shareholders include NEA Management Company, LLC (4.19M shares), FRAZIER MANAGEMENT LLC (3.57M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (3.28M shares), Novo Holdings A/S (2.45M shares), RiverVest Venture Management LLC (1.92M shares), Rock Springs Capital Management LP (1.54M shares), AXA S.A. (993K shares), VANGUARD GROUP INC (808K shares), BlackRock Inc. (772K shares), and FRANKLIN RESOURCES INC (484K shares).
This table shows the top 80 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.